Wall Street brokerages forecast that Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) will post earnings per share of ($0.45) for the current quarter, according to Zacks. Three analysts have made estimates for Crinetics Pharmaceuticals’ earnings. The highest EPS estimate is ($0.38) and the lowest is ($0.50). Crinetics Pharmaceuticals posted earnings per share of ($2.41) in the same quarter […]